Natera stock price target raised to $255 from $251 at RBC Capital

Published 08/08/2025, 14:42
Natera stock price target raised to $255 from $251 at RBC Capital

Investing.com - RBC Capital has raised its price target on Natera (NASDAQ:NTRA) to $255.00 from $251.00 while maintaining an Outperform rating on the stock. The company, currently valued at $22.34 billion, has demonstrated impressive revenue growth of 51.5% over the last twelve months, according to InvestingPro data.

The price target adjustment follows what RBC Capital described as "another noteworthy quarter" for the liquid biopsy company, with strength demonstrated across all categories. The company maintains a healthy financial position with a current ratio of 3.87 and a strong gross profit margin of 61.79%.

RBC Capital highlighted particular strength in Signatera volume and average selling prices (ASPs), which contributed to significant revenue outperformance and a subsequent guidance raise by the company. While InvestingPro analysis suggests the stock is currently trading above its Fair Value, the company maintains a "GREAT" overall financial health score.

The investment firm stated that Natera remains its "favorite liquid biopsy idea" and suggested that the company continues to command a premium multiple due to the scarcity of high-growth names in the healthcare sector.

RBC Capital also noted that Natera has multiple "shots on goal" across near, medium, and long-term timeframes, though specific details about these opportunities were not elaborated upon.

In other recent news, Natera reported its second-quarter 2025 earnings, showcasing a mixed financial performance. The company achieved a revenue of $546.6 million, exceeding forecasts by 14.85%, although its earnings per share (EPS) fell short of expectations at -$0.74 compared to the anticipated -$0.62. Despite the EPS miss, the strong revenue growth led to a positive market reaction. Bernstein SocGen Group raised its price target for Natera to $205, citing the impressive revenue figures, while maintaining an Outperform rating. Similarly, TD Cowen increased its price target to $215 from $200, highlighting the company’s robust performance across key metrics and maintaining a Buy rating. These developments reflect the positive sentiment among analysts regarding Natera’s recent achievements.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.